Form 4 for BIIB Biogen
Accepted 2026-06-11 17:09:24 ET · period of report 2026-06-09 · accession 0000875045-26-000052 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-11 17:09 | 2026-06-09 | BIIB | Freire Maria C | Dir | A - Grant | $0.00 | +2,005 | 8,820 | +29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-09 | A | A | 2,005 | $0.00 | 8,820 | D | — | — | (F1) The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026. |